Wall Street analyst estimates for PMGC Holdings Inc. (ELAB): consensus price target, buy/hold/sell recommendations and forecasts for revenue, EPS and EBITDA for the upcoming fiscal years.
PMGC Holdings Inc. functions as a biopharmaceutical firm, primarily dedicated to sourcing and advancing innovative aesthetic and therapeutic solutions. Its flagship product, EL-22, is a pioneering engineered probiotic designed to tackle the critical challenge of maintaining muscle mass during weight reduction regimens, especially those utilizing GLP-1 receptor agonists.
Valuation Ratios
| Price / Book | 0.14 |
| EV / EBITDA | -0.02 |
| Dividend Yield | 0.00% |
Income Statement (10y)
| Year | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Revenue | 0 | $827 | $766277 | 0 | $2.5M | $590084 |
| Cost of Revenue | 0 | $88 | $318968 | $554 | $670197 | $515273 |
| Gross Profit | 0 | $739 | $447309 | -$554 | $1.8M | $74811 |
| Research & Development | $118857 | $123632 | $228747 | $7410 | $104654 | $147010 |
| Selling, General & Admin | $102987 | $634334 | $1.7M | $1.1M | $855764 | $1.6M |
| Operating Expenses | $221844 | $785801 | $2.2M | $1.1M | $3.7M | $7.5M |
| Operating Income | -$221844 | -$785062 | -$1.8M | -$1.1M | -$1.9M | -$7.4M |
| EBITDA | 0 | -$781982 | -$1.8M | -$1.1M | -$3.2M | -$7.3M |
| Interest Expense | 0 | 0 | $2629 | 0 | $735197 | $547128 |
| Pre-tax Income | -$222910 | -$784739 | -$1.8M | -$1.7M | -$4.0M | -$7.7M |
| Income Tax | 0 | 0 | 0 | 0 | 0 | $30972 |
| Net Income | -$222910 | -$784739 | -$1.8M | -$4.3M | -$6.2M | -$7.7M |
| EPS | $-19.79 | $-887.71 | $-158.40 | $-477946.33 | $-65923.20 | $-3787.40 |
| EPS (Diluted) | $-19.79 | $-887.71 | $-158.40 | $-1511.43 | $-65923.20 | $-3787.40 |
| Shares Outstanding (Diluted) | $11263 | $884 | $11344 | $2846 | $95 | $2035 |
Price
| Price | $4.77 |
| Market Cap | $2M |
| Exchange | NASDAQ |
| Country | US |
Related companies: ATXI · BCTXZ · DRMA · MLEC · NCEL · NKGN · PBM
Explore sector: Healthcare · Biotechnology
More sections of ELAB: Overview · Financials · Valuation · Statistics · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks